Jun Amaki

437 total citations
19 papers, 154 citations indexed

About

Jun Amaki is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, Jun Amaki has authored 19 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Jun Amaki's work include Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Jun Amaki is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Jun Amaki collaborates with scholars based in Japan, United States and France. Jun Amaki's co-authors include Kiyoshi Ando, Yoshiaki Ogawa, Hiroshi Kawada, Naoya Nakamura, Minoru Kojima, Ryujiro Hara, Makoto Onizuka, Shinichiro Machida, Ai Sato and Ken Ohmachi and has published in prestigious journals such as Blood, Scientific Reports and Cancer Science.

In The Last Decade

Jun Amaki

16 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Amaki Japan 6 98 64 42 36 23 19 154
Kento Umino Japan 8 31 0.3× 41 0.6× 65 1.5× 19 0.5× 35 1.5× 23 148
Chantana Polprasert Thailand 9 78 0.8× 87 1.4× 89 2.1× 77 2.1× 26 1.1× 42 226
Konstantinos Christofyllakis Germany 6 64 0.7× 45 0.7× 26 0.6× 13 0.4× 32 1.4× 30 149
George Chan New Zealand 7 47 0.5× 57 0.9× 79 1.9× 61 1.7× 30 1.3× 18 172
James E. Radford United States 6 84 0.9× 42 0.7× 90 2.1× 29 0.8× 30 1.3× 8 209
Tuğrul Elverdi Türkiye 7 48 0.5× 37 0.6× 71 1.7× 34 0.9× 13 0.6× 44 164
Simona Sammassimo Italy 7 79 0.8× 55 0.9× 70 1.7× 23 0.6× 27 1.2× 26 158
Iván Murrieta-Álvarez Mexico 8 36 0.4× 72 1.1× 70 1.7× 11 0.3× 29 1.3× 33 166
Kar Fai Chow United States 8 38 0.4× 82 1.3× 17 0.4× 20 0.6× 46 2.0× 20 159
Massimo Granai Italy 8 113 1.2× 88 1.4× 7 0.2× 49 1.4× 38 1.7× 28 184

Countries citing papers authored by Jun Amaki

Since Specialization
Citations

This map shows the geographic impact of Jun Amaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Amaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Amaki more than expected).

Fields of papers citing papers by Jun Amaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Amaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Amaki. The network helps show where Jun Amaki may publish in the future.

Co-authorship network of co-authors of Jun Amaki

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Amaki. A scholar is included among the top collaborators of Jun Amaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Amaki. Jun Amaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Onizuka, Makoto, Eri Kikkawa, Shinichiro Machida, et al.. (2023). Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia. PubMed. 6(3). 80–86. 2 indexed citations
2.
Onizuka, Makoto, Tadashi Imanishi, Kaito Harada, et al.. (2023). Donor cord blood aging accelerates in recipients after transplantation. Scientific Reports. 13(1). 2603–2603. 3 indexed citations
3.
Harada, Kaito, Makoto Onizuka, Ryujiro Hara, et al.. (2022). Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection. Journal of Infection and Chemotherapy. 28(9). 1279–1285.
4.
Tomomatsu, Katsuyoshi, Naoki Okada, Takahisa Takihara, et al.. (2020). Transudative Pleural Effusion Associated with Extramedullary Hematopoiesis. Internal Medicine. 60(3). 449–452.
5.
Onizuka, Makoto, Jun Amaki, Shinichiro Machida, et al.. (2019). Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide. PubMed. 2(1). 1–4. 2 indexed citations
6.
Amaki, Jun, et al.. (2018). Three cases of spontaneous splenic rupture in malignant lymphoma. International Journal of Hematology. 108(6). 647–651. 5 indexed citations
7.
Miyazaki, Kana, Masahiko Oguchi, Ritsuro Suzuki, et al.. (2018). Incidence and Risk Factors of Central Nervous System Relapse in Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: An Analysis of Nkea Study. Blood. 132(Supplement 1). 2935–2935. 1 indexed citations
8.
Onizuka, Makoto, Minoru Kojima, Shinichiro Machida, et al.. (2017). Successful treatment with low-dose nivolumab in refractory Hodgkin lymphoma after allogeneic stem cell transplantation. International Journal of Hematology. 106(1). 141–145. 29 indexed citations
9.
Kojima, Minoru, Naoya Nakamura, Jun Amaki, et al.. (2017). Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma following tyrosine kinase inhibitor treatment for chronic myelogenous leukemia. Journal of Clinical and Experimental Hematopathology. 57(2). 69–73. 9 indexed citations
10.
Amaki, Jun, et al.. (2016). The formation of an aberrant PAX5 transcript in a patient with mixed phenotype acute leukemia harboring der(9)t(7;9)(q11.2;p13). Leukemia Research Reports. 5. 14–17. 1 indexed citations
11.
Machida, Shinichiro, et al.. (2016). Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Bone Marrow Transplantation. 52(2). 307–309. 4 indexed citations
12.
Kojima, Minoru, Ryujiro Hara, Jun Amaki, et al.. (2016). Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report. Leukemia Research Reports. 5. 11–13. 7 indexed citations
13.
Onizuka, Makoto, Shinichiro Machida, Ai Sato, et al.. (2016). Lymphoid malignancy is a risk factor for CMV infection in the early phase of allogeneic stem cell transplantation.. 5(2). 41–50. 1 indexed citations
14.
15.
Amaki, Jun, Makoto Onizuka, Ken Ohmachi, et al.. (2015). Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy. International Journal of Hematology. 101(6). 543–553. 16 indexed citations
16.
Kojima, Minoru, Akitada Ichinose, Masayoshi Souri, et al.. (2015). Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies. International Journal of Hematology. 103(3). 341–347. 5 indexed citations
17.
Sato, Ai, Naoya Nakamura, Minoru Kojima, et al.. (2014). Clinical outcome of Epstein–Barr virus‐positive diffuse large B‐cell lymphoma of the elderly in the rituximab era. Cancer Science. 105(9). 1170–1175. 57 indexed citations
18.
Onizuka, Makoto, Shinichiro Machida, Jun Amaki, et al.. (2013). ACE deletion polymorphism is associated with a high risk of non-infectious pulmonary complications after stem cell transplantation. International Journal of Hematology. 99(2). 175–183. 5 indexed citations
19.
Matsushita, Hiromichi, Makoto Onizuka, Naoya Nakamura, et al.. (2012). Association of Promyelocytic Leukemia Protein with Expression of IL-6 and Resistance to Treatment in Multiple Myeloma. Acta Haematologica. 128(4). 213–222. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kento Umino Breakdown of academic impact, for papers by Chantana Polprasert Breakdown of academic impact, for papers by Konstantinos Christofyllakis Breakdown of academic impact, for papers by George Chan Breakdown of academic impact, for papers by James E. Radford Breakdown of academic impact, for papers by Tuğrul Elverdi Breakdown of academic impact, for papers by Simona Sammassimo Breakdown of academic impact, for papers by Iván Murrieta-Álvarez Breakdown of academic impact, for papers by Kar Fai Chow Breakdown of academic impact, for papers by Massimo Granai
Rankless by CCL
2026